Gallium/Indium-Promoted [4 + 2] Annulation of 2‑Aminobenzonitriles with Alkynes and Dimerization of 2‑Aminobenzonitriles: One-Pot Access to 4‑Aminoquinolines and 4‑Amino-2-Arylquinazolines Authors: Norio Sakai, Mio Ishii, Shuji Yamauchi, Yohei Ogiwara, Kento Ishida Published: 2026 ABSTRACT Aminoquinolines are key structural motifs in many biologically active substances. Herein, we report that the [4 + 2] annulation reactions of 2-aminobenzonitriles with nonactivated aryl/alkyl alkynes are performed in the presence of a group 13 Lewis acid (GaCl3 or InBr3) to produce a variety of 4-amino-2-substituted quinolines in moderate to good yields. This cycloaddition reaction was applicable to various terminal alkynes containing a halogen atom, an ester moiety, and a silyl group, and internal alkynes. Notably, the use of GaCl3 effectively promoted the dimerization of 2-aminobenzonitriles, leading to the preparation of 4-amino-2-arylquinazoline derivatives in good yields. Introduction Aminoquinolines, particularly 4-aminoquinolines, are some of the most useful nitrogen-containing heterocycles and are common structural motifs in many biologically active substances, such as antimalarial drugs and antitumor agents. Consequently, many direct intermolecular approaches to the 4-aminoquinoline skeleton have been developed. , In particular, annulation reactions that generate 4-aminoquinoline derivatives via the coupling of 2-aminobenzonitrile with suitable carbonyl derivatives as ketones and amides, or with alkynes, have been extensively investigated. For instance, in a stepwise approach performed using a carbonyl compound, the couplings of 2-aminobenzenitriles with ketones (or amides) in the presence of a Brønsted acid or a dehydrating agent generated imine intermediates that were subsequently subjected to base- or acid-promoted cyclization to produce 4-aminoquinoline derivatives (Scheme a). , Additionally, during a one-pot synthesis, Lewis acids, such as TiCl4, CuBTC, ZnCl2, BF3OEt2, AlCl3, InCl3, and SnCl4, or protic acids promoted the coupling of 2-aminobenzenitriles with suitable ketones to yield 4-aminoquinoline derivatives (Scheme b). In these examples, each acid promotor played a dual role, acting as both condensation agent between the 2-aminobenzonitriles and carbonyl compounds, and as a cyclization promoter for the in situ-generated intermediates. Diverse Approaches to 4-Aminoquinolines via the Couplings of 2-Aminobenzonitriles with Suitable Carbon Sources Another skillful approach to this useful nitrogen-containing skeleton is the base- and metal-promoted coupling of 2-aminobenzonitriles with electron-deficient alkynes to produce 4-aminoquinolines (Scheme c). Additionally, the metal-catalyzed coupling of 2-aminobenzonitriles with ynamides bearing an electron-donating group (EDG), which behave as electron-rich alkynes yielded substituted 4-aminoquinolines (Scheme d). In these examples, single metal catalysts, such as ZnCl2 and (Ph3P)­AuNTf2, a dual-metal catalyst that composed of Cu­(OAc)2 and Zn­(OTf)2, and a Me3SiOTf/TfOH system have been employed. Although these approaches can incorporate various types of alkynes to produce valuable 4-aminoquinoline derivatives, most alkynes employed to date have been limited to activated alkynes containing an electron-withdrawing group and a sulfonamide group. Consequently, direct reactions between 2-aminobenzonitriles and simple aryl or alkyl alkynes in the presence of a Lewis acid are relatively unknown. In this context, our group previously reported the indium­(III)-promoted dimerization of 2-ethynylanilines to generate 4-methylquinoline derivatives (Scheme e). It was found that selective activation of the alkyne moiety by a relatively soft Lewis acid, a trivalent indium compound, through π-interaction was the key step during dimerization. The current study therefore, focuses on the design of a straightforward route to 4-aminoquinoline frameworks via the [4 + 2] annulation of 2-aminobenzonitriles with simple alkynes in the presence of group 13 Lewis acid (Scheme f­(a)). Both gallium­(III)- and indium­(III)-promoted reactions are evaluated for the single-step synthesis of 4-methylquinoline derivatives. Moreover, the application of this Lewis acid-promoted dimerization of 2-aminobenzonitriles is demonstrated in the direct synthesis of useful 4-amino-2-arylquinazoline derivatives (Scheme f­(b)). Results and Discussion Initially, the reaction conditions were optimized using 2-aminobenzonitrile (1a) and 1-hexyne (2) as model substrates (Table ). When the reaction of 1a with 2 (1.1 equiv) was performed in the presence of GaCl3 (1 equiv) in toluene at 80 °C for 1 h, the desired 4-amino-2-butylquinoline (3a) was obtained in 42% yield (entry 1). The structure of 3a was confirmed by NMR spectroscopy and mass spectrometry. Since the side chain (C4) of 3a can adopt a substructure equivalent that of a biologically active compound, Tacrine (9-amino-1,2,3,4-tetrahydroacridine), quinoline 3a was used as a model compound. The use of 1,4-dioxane (dioxane), which enhanced the solubility of GaCl3 increased the yield of 3a to 62%, while 1,2-dichloroethane (1,2-DCE) produced 3a in 69% yield (entries 2 and 3). In contrast, the use of 0.5 equiv of GaCl3 lowered the yield of 3a to 34% (entry 4). This is presumed to be due to a decrease in the catalytic activity of the gallium Lewis acid caused by the coordination of the basic amino group. Aluminum compounds as AlCl3 and AlBr3 were also examined; however, they failed to promote cyclization (entries 5 and 6). Then, the use of indium compounds as InCl3, InBr3, and InI3 led to decrease the yields (entries 7–9). The reaction performed using InBr3 in o-dichlorobenzene (o-DCB) at 120 °C produced quinoline 3a in 72% yield (entry 10). Moreover, when the mixture of 1a and 2 was treated with InBr3 (1 equiv) in toluene at 120 °C, the desired annulation proceeded cleanly to afford quinoline 3a in 80% isolated yield (entry 11). Additionally, as a control experiment, the reaction of 1a with 2 was carried out in the absence of a Lewis acid catalyst. As expected, the annulation reaction did not proceed, and the starting materials were recovered (entries 12 and 13). 1Optimization of Reaction Conditions entryLewis acid (1 equiv)solventtemp (°C)GC yield of 3a (%)1GaCl3 toluene80422GaCl3 dioxane 100623GaCl3 1,2-DCE 8071 (69) 4GaCl3 1,2-DCE80345AlCl3 1,2-DCE80ND 6AlBr3 1,2-DCE80ND 7InCl3 1,2-DCE80368InBr3 1,2-DCE80509InI3 1,2-DCE804710InBr3 o-DCB 1207211InBr3 toluene120(80) 12----toluene120NR13----1,2-DCE80NRaStandard conditions: 1a (0.5 mmol), 2 (0.55 mmol), Lewis acid (0.5 mmol), solvent (0.8 mL), 80 °C (bath temperature), 1 h.b1,4-Dioxane.c1,2-Dichloroethane.dIsolated yield.eGaCl3 (0.5 equiv).fND = not detected.g o-Dichlorobenzene. Optimization of Reaction Conditions Standard conditions: 1a (0.5 mmol), 2 (0.55 mmol), Lewis acid (0.5 mmol), solvent (0.8 mL), 80 °C (bath temperature), 1 h. 1,4-Dioxane. 1,2-Dichloroethane. Isolated yield. GaCl3 (0.5 equiv). ND = not detected. o-Dichlorobenzene. With the optimal conditions in hand for reactions involving GaCl3 in 1,2-DCE (Method A) and InBr3 in toluene (Method B), the substrate scope was investigated using 2-aminobenzonitriles 1b–1i (Scheme ). Initially, the annulation reactions were performed using methyl-substituted 2-aminobenzonitriles 1b–1e and 1-hexyne (2) were examined in the presence of GaCl3 or InBr3. In all cases, the desired annulation reactions occurred to produce the corresponding 2-butyl-substituted 4-aminoquinoline derivatives 3b–3e in low to good yields. The results suggest that InBr3 tends to be more effective than GaCl3. Interestingly, when the reaction using 2-amino-4-methylbenzonitrile (1c) was treated with GaCl3 at 80̊C in 1,2-DCE, the desired 4-aminoquinoline derivative 3c along with the formation of a trace amount of 2-(2-amino-4-methylphenyl)-4-amino-7-methylquinazoline (4) was observed via the dimerization of 1c (see Scheme ). Additionally, for the reaction of 2-amino-6-methylbenzonitrile (1d) performed in the presence of GaCl3 and InBr3, the corresponding stereoisomer 3d′ was obtained along with target 3d. Similarly, when 2-amino-2-methylbenzonitrile (1e) were treated with GaCl3 and InBr3, the expected quinoline 3e was formed in 48% and 83% yields, respectively. Only when using InBr3, the formation of a trace amount of stereoisomer 3e′ was observed. When the [4 + 2] annulation with 2-aminobezonitrile 1f bearing two methoxy groups was then treated with InBr3, the corresponding stereoisomers 3f and 3f′ was obtained. In contrast, when the reactions of 2-amino-6-chlorobenzonitrile (1g) performed in the presence of GaCl3 and InBr3, the desired 4-amino-2-butyl-5-chloroquinoline (3g) was obtained in yields of 6% and 24%, respectively. In this case, the formation of a stereoisomer like compounds 3d′ and 3f′ shown above was not observed. In similar, 2-amino-4-chlorobenzonitrile (1h) underwent cyclization to afford 4-amino-2-butyl-5-chloroquinoline (3h) in good yield. Although the annulation of 1i bearing a strongly electron-withdrawing nitro group did not proceed in the presence of GaCl3, the reaction using InBr3 successfully proceeded to produce the desired quinoline 3i. Thus, when a similar annulation reaction with substrate 1j bearing a trifluoromethyl group was examined in the presence of InBr3, the desired [4 + 2] annulation proceeded to afford the corresponding quinoline 3j in good yield along with trace amount of stereoisomer 3j′. From the above results, it is suggested that when an electron-donating group is bonded onto the aryl group of 2-aminobenzonitriles, there is a tendency for stereoisomers to be formed. Substrate Scope of the 2-Aminobenzonitriles aIsolated yield. bFormation of 4-aminoquinazoline derivative 4 was observed. cFormation of a trace amount of stereoisomer 3e′ was observed. Isolated yield. Formation of 4-aminoquinazoline derivative 4 was observed. Formation of a trace amount of stereoisomer 3e′ was observed. The substrate scope was subsequently investigated for the reactions of 2-aminobenzonitrile (1a) with different aryl alkynes (Scheme ). Initially, the reaction of 1a with phenylacetylene (5a) was performed using GaCl3 in 1,2-DCE, affording the corresponding quinoline 6aa in 71% yield. The reaction of 1a with arylalkynes bearing a tolyl group also produced the desired 4-aminoquinolines 6ab and 6ac in good yields. Moreover, substrates bearing an electron-withdrawing substituent, such as a trifluoromethyl and a fluorine group, yielded the corresponding 4-aminoquinolines 6ad–6af in high yields. To our delight, this annulation of 1a was successfully extended to aryl alkyne 5g bearing a thiophen ring, producing the expected quinoline derivative 6ag in moderate yield. This reaction was also attempted using InBr3 in toluene; however, no improvement in yield was observed. In contrast, the reaction of 1a with 3-ethynylpyridine (5h) failed to produce the desired quinoline 6ah in the presence of either GaCl3 or InBr3, potentially due to the deactivation of these Lewis acids by the strongly basic pyridine ring. As another example, the coupling of 2-amino-6-fluorobenzonitrile (1k) with phenylacetylene (5a) was examined using InBr3, producing the corresponding quinoline derivative 6ka in 86% yield. X-ray crystallographic analysis of 6ka unambiguously confirmed the preparation of a 4-amino-2-arylquinoline skeleton. Substrate Scope of the Aryl Alkynes aIsolated yield Isolated yield Subsequently, the coupling reactions of 2-aminobenzonitrile (1a) with various alkynes 7a–7e were examined under the optimal conditions involving GaCl3 and InBr3 (Scheme ). Initially, the reaction of 1a with 6-chloro-1-hexyne (7a) was performed in GaCl3 in 1,2-DCE at 80 °C, contrary to expectations, producing 4-amino-3-(4-chlorobutyl)-2-methylquinoline (8) in 23% yield. This result was comparable to the above results that yielded stereoisomers 3d′ and 3f′ (see Scheme ). There is no clear explanation of this result at this stage. Under the optimal conditions with GaCl3, the coupling of 1a with ethyl propionate (7b) yielded 3-substituted quinoline 9 in a regioselective manner in 91% yield. Notably, the conventional studies have reported that the coupling of 1a with electron-deficient alkynes proceeded only in the presence of typical bases. , Thus, assuming that 2-aminobenzonitrile itself functions as a base, the annulation of 1a with 7b was attempted in the absence of a Lewis acid. However, the desired quinoline derivative 9 was not produced. This result demonstrated that GaCl3 is essential for the activating reaction substrates. Interestingly, the coupling reaction between 1a and trimethylsilylacetylene (7c) in the presence of GaCl3 produced a 2,3-unsubstituted quinoline, 4-aminoquinoline (10), in good yield. Furthermore, as an example of an internal aliphatic alkyne, 6-dodecyne (6e) was reacted in the presence of GaCl3 affording the expected 2,3-disubstituted quinoline derivative 11; using InBr3 improved the yield slightly to 60%. Moreover, the reaction between 1a and an internal aromatic alkyne, diphenylacetylene (6f), in InBr3/toluene at 120 °C produced the desired 4-amino-2,3-diphenylquinoline (12) in moderate yield. Under the optimal conditions involving InBr3, employment of 1-octyne (7f), which have a longer carbon chain than 1-hexyne, afforded 4-amino-2-hexylquinoline (13) was obtained as the sole product. Moreover, when the reaction of 1a with an unsymmetrical alkyne, 2-hexyne (7g), was carried out using InBr3, complete consumption of the starting material 1a was observed; however, 2-methyl-substituted quinoline derivative 14 was obtained in only 8% yield along with a trace amount of regioisomer 14′. At this stage, there is no clear explanation for the reason for the low yield of the annulation with an unsymmetrical alkyne. Unfortunately, 2-amino-3-cyanothionphene (1l) was not applicable to this type of [4 + 2] annulation, and most of the starting material was recovered. Substrate Scope of Various Alkynes aIsolated yield. bPerformed in the absence of a Lewis acid. Isolated yield. Performed in the absence of a Lewis acid. Subsequently, the developed method was applied to the large-scale synthesis of 4-aminoquinoline derivative 6aa (Scheme ). Specifically, the coupling of 1a with phenylacetylene (5a) in the presence of InBr3 afforded 6aa in 67% yield (1.25 g) after purification by column chromatography. Gram-Scale Synthesis of Quinoline 6aa Notably, during the synthesis of 4-amino-2-butyl-7-methylquinoline (3d) via the GaCl3-promoted coupling of 2-amino-4-methylbenzonitrile (1d) with alkyne 2a, a small amount of quinazoline derivative 4 was observed (see Scheme ). Although this type of Lewis acid-promoted dimerization of 2-aminobenzonitriles has not been studied extensively, our group previously reported the related dimerization, in which InBr3 effectively promoted the dimerization of 2-ethynylanilines to afford the corresponding quinoline derivatives. Considering the importance of the quinazoline-4-amine/imine skeleton in various biologically active substances, this result motivated the development of a unique and direct preparation of valuable quinazoline derivatives. Following optimization of the dimerization conditions, it was found that the protocol for 4-amino-2-arylquinoline synthesis could be extended to the direct construction of a quinazoline skeleton. Specifically, the treatment of 1a with GaCl3 in toluene at 120 °C for 20 h promoted the desired dimerization, yielding the corresponding quinazoline derivative, 2-(2-aminophenyl)-4-aminoquinazoline (16), in 64% isolated yield; the use of InBr3 led to a slightly reduced yield (Scheme a). Similarly, the reaction of 2-amino-4-methylbenzonitrile (1d) and 2-amino-4-chlorobenzonitrile (1h) under identical GaCl3-promoted conditions produced 2-(2-amino-4-methylphenyl)-4-amino-7-methylquinazoline (4) and 2-(2-amino-4-chlorophenyl)-4-amino-7-chloroquinazoline (17) in yields of 53% and 69% yields, respectively (Scheme b,c). These results indicate that the electronic effect of the aromatic substituent did not influence the reaction outcome. The structures of these quinazoline skeletons were unequivocally established by X-ray crystallographic analysis using a single crystal of quinazoline 4. Group 13 Metal-Promoted Dimerization of 2-Aminobenzonitriles to Generate 4-Amino-2-arylquinazolines aIsolated (NMR) yield. Isolated (NMR) yield. Based on our previous work, in which it was found that the indium-catalyzed hydroamination of aryl or alkyl alkynes with anilines/hydrazones proceeded in a Markovnikov-type manner, it was considered that the annulation reactions between 2-aminobenzonitriles and alkynes would proceed similarly (Scheme ). As propose in Scheme a, the reaction of aryl alkynes with 2-aminobenzonitrile begins with Lewis acid-activated Markovnikov-type hydroamination, affording the corresponding enamine intermediate A. Subsequently, enamine intermediate A cyclizes to form cycloadduct B, followed by aromatization to produce 4-amino-2-arylquinoline C. For 2-aminobenzonitriles bearing an electron-donating group (Scheme b), in most cases, an initial hydroamination proceeds in a manner analogous to that shown in Scheme a to generate enamine intermediate D, then enamine D cyclizes to yield 4-amino-2-alkylquinoline E as a major product. However, a portion of enamine D bearing an electron-rich aryl group tends to isomerize to a more stable disubstituted enamine intermediate G through imine intermediate F, followed by a rapid cyclization of enamine G to give 4-amino-3-alkyl-2-methylquinoline H as a minor product. Notably, this type of isomerization has also been observed in the presence of titanium and zinc catalysts. For the dimerization of 2-aminobenzonitrile (Scheme c), considering on our previous work on the indium-promoted dimerization of 2-ethynylanilines, it was proposed that an amino group of 2-aminobenzonitrile adds to a nitrile moiety of another 2-aminobenzonitrile, forming cycloadduct I. Subsequently, aromatization of I affords 4-amino-2-arylquinazoline J. Plausible Reaction Mechanisms Conclusion This study demonstrated that the gallium- or indium-promoted coupling of 2-aminobenzonitriles with various terminal or internal alkynes produced a variety of 4-amino-2-substituted quinoline derivatives in moderate to good yields. It was also confirmed that GaCl3 effectively promoted the dimerization of 2-aminobenzonitriles, leading to the direct production of 4-amino-2-arylquinazoline derivatives in good yields. Notably, the group 13 Lewis acids investigated in this work (i.e., GaCl3 and InBr3) effectively activated the triple bonds of both a simple alkyne and a 2-aminobenzonitrile, facilitating subsequent annulation to produce valuable nitrogen-containing heterocycles in practical yields. Ongoing efforts in our group are focused on the coupling reaction using other unsaturated compounds to further survey in this reaction system. Experimental Section General Experimental Methods All reactions were carried out under a nitrogen atmosphere, unless otherwise noted. Toluene and dioxane were distilled over Na-benzophenone prior to use. 1,2-DCE was dried over calcium chloride and calcium hydride prior to subsequent distillation. O-DCB was dried over calcium chloride and calcium hydride prior to distillation under reduced pressure. 2-Aminobenzonitriles 1a–k, 2-amino-3-cyanothionphene (1l), 1-hexyne (2), alkynes 5a–h, and alkynes 7a–g, were commercially available and were purified according to conventional distillation and recrystallization protocols prior to use. The Lewis acids (AlCl3, AlBr3, GaCl3, InCl3, InBr3, and InI3) were also commercially available and were used without further purification. Column chromatography was performed using silica gel. The 1H NMR spectra were measured at 500 or 400 MHz using tetramethylsilane as an internal standard (0.00 ppm) or using the center peak of dimethyl sulfoxide (2.5 ppm). The 13C­{1H} NMR spectra were measured at 125 or 100 MHz using the center peak of chloroform (77.0 ppm) or dimethyl sulfoxide (39.5 ppm) as a reference. The 19F NMR spectra were measured at 470 or 376 MHz using trifluorotoluene as an external standard (−62.6 ppm) as a reference. High-resolution mass spectra (HRMS) were performed using NBA (3-nitrobenzyl alcohol) as the matrix. General Procedure for the Synthesis of 4-Aminoquinoline Derivatives (Method A) To a screw-capped vial with a stir bar in a N2-filled glovebox, GaCl3 (88.0 mg, 0.500 mmol) was added. The vial was then sealed and removed from the glovebox, and 1,2-DCE (0.8 mL), a 2-aminobenzonitrile derivative (0.5 mmol), and an alkyne (0.55 mmol) were successively added. The mixture was heated at 80 °C (bath temperature) for 1 h prior to quenching with a saturated aqueous Na2CO3 solution (3 mL). Subsequently, the aqueous layer was extracted with chloroform (5 × 5 mL). The combined organic layer was dried over anhydrous Na2SO4, filtered, and evaporated under reduced pressure. The crude material was purified via silica gel column chromatography (eluent: hexane/ethyl acetate/triethylamine = 4:1:0.1) or preparative thin-layer chromatography to yield the corresponding 4-aminoquinoline derivative. General Procedure for the Synthesis of 4-Aminoquinoline Derivatives (Method B) To a screw-capped vial with a stir bar in a N2-filled glovebox, InBr3 (177 mg, 0.500 mmol) was added. The vial was then sealed and removed from the glovebox, and toluene (0.8 mL), a 2-aminobenzonitrile derivative (0.5 mmol), and an alkyne (0.55 mmol) were successively added. The mixture was heated at 120 °C (bath temperature) for 1 h prior to quenching with a saturated aqueous Na2CO3 solution (3 mL). Subsequently, the aqueous layer was extracted with chloroform (5 × 5 mL). The combined organic layer was dried over anhydrous Na2SO4, filtered, and evaporated under reduced pressure. The crude material was purified via silica gel column chromatography (eluent: hexane/ethyl acetate/triethylamine = 5:5:0.2) or preparative thin-layer chromatography to yield the corresponding 4-aminoquinoline derivative. 4-Amino-2-butylquinoline (3a) General procedure was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and 1-hexyne (45.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 3a as a brown oil (Method A: 69.0 mg, 69%; Method B: 80.0 mg, 80%); 1H NMR (400 MHz, CDCl3): δ 7.96 (d, J = 8.2 Hz, 1H), 7.73 (d, J = 8.2 Hz, 1H), 7.58 (t, J = 8.2 Hz, 1H), 7.34 (t, J = 8.2 Hz, 1H), 6.48 (s, 1H), 5.01 (br s, 2H), 2.79 (t, J = 7.8 Hz, 2H), 1.73 (quint, J = 7.8 Hz, 2H), 1.39 (sext, J = 7.4 Hz, 2H), 0.91 (t, J = 7.4 Hz, 3H); 13C­{1H} NMR (100 MHz, CDCl3): δ 163.3, 149.9, 148.4, 129.2, 128.7, 123.9, 120.2, 117.5, 103.1, 38.8, 32.1, 22.6, 13.9; HRMS (FAB-Magnetic Sector): calcd for C13H17N2 [M + H]+, 201.1392; found, 201.1409. 4-Amino-2-butyl-6-methylquinoline (3b) General procedure was followed with 2-amino-5-methylbenzonitrile (66.1 mg, 0.500 mmol) and 1-hexyne (45.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 3b as a pale yellow solid (Method A: 72.2 mg, 67%; Method B: 73.6 mg, 69%): 1H NMR (400 MHz, CDCl3): δ 7.83 (d, J = 8.8 Hz, 1H), 7.47–7.41 (m, 2H), 6.46 (s, 1H), 4.76 (br s, 2H), 2.78 (t, J = 7.8 Hz, 2H), 2.46 (s, 3H), 1.76–1.68 (m, 2H), 1.45–1.35 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H); 13C­{1H} NMR (100 MHz, CDCl3): δ 162.5, 149.1, 147.0, 133.6, 131.3, 128.7, 119.1, 117.4, 103.3, 38.9, 32.2, 22.7, 21.5, 13.9; HRMS (FAB-Magnetic Sector): calcd for C14H19N2 [M + H]+, 215.1548; found, 215.1552. 4-Amino-2-butyl-7-methylquinoline (3c) General procedure was followed with 2-amino-4-methylbenzonitrile (66.1 mg, 0.500 mmol) and 1-hexyne (45.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 5:5:0.2) afforded 3c as a white solid (Method A: 24.6 mg, 23%; Method B: 70.8 mg, 66%); 1H NMR (400 MHz, CDCl3): δ 7.74 (s, 1H), 7.60 (d, J = 8.7 Hz, 1H), 7.20 (dd, J = 8.7, 1.4 Hz, 1H), 6.44 (s, 1H), 4.73­(br s, 2H), 2.78 (t, J = 7.8 Hz, 2H), 2.49 (s, 3H), 1.73 (quint, J = 7.8 Hz, 2H), 1.40 (sext, J = 7.8 Hz, 2H), 0.93 (t, J = 7.3 Hz, 3H); 13C­{1H} NMR (100 MHz, CDCl3): δ 163.4, 149.5, 148.8, 139.3, 128.2, 126.0, 119.7, 115.4, 102.8, 39.0, 32.2, 22.7, 21.6, 14.0; HRMS (FAB-Magnetic Sector): calcd for C14H19N2 [M + H]+, 215.1548; found, 215.1547. 4-Amino-2-butyl-5-methylquinoline (3d) and 4-Amino-3-propyl-2,5-methylquinoline (3d′) General procedure was followed with 2-amino-6-methylbenzonitrile (66.1 mg, 0.500 mmol) and 1-hexyne (45.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 5:5:0.2) afforded 3d + 3d′ as a white solid (Method A: 53 mg, 49% (3d/3d′ = 77/23); Method B: 73.4 mg, 69%, 3d/3d′ = 59/41); For 3d; 1H NMR (400 MHz, CDCl3): δ 7.77 (d, J = 8.7 Hz, 1H), 7.39 (t, J = 7.5 Hz, 1H), 7.04 (d, J = 6.9 Hz, 1H), 6.38 (s, 1H), 4.95 (br s, 2H), 2.89 (s, 3H), 2.74 (t, J = 7.8 Hz, 2H), 1.75–1.67 (m, 2H), 1.40 (td, J = 14.9, 7.5 Hz, 2H), 0.93 (t, J = 7.3 Hz, 3H); For 3d′; 1H NMR (400 MHz, CDCl3): δ 7.72 (d, J = 8 Hz, 1H), 7.34 (t, J = 6.6 Hz, 1H), 7.03 (s, 1H), 4.88 (br s, 2H), 2.99 (s, 3H), 2.87 (s, 2H), 2.56 (t, J = 8 Hz, 1H), 1.62–1.53 (m, 2H), 1.04 (t, J = 7.4 Hz, 3H); 13C­{1H} NMR (100 MHz, CDCl3): δ 162.4, 157.1, 152.3, 150.7, 148.7, 148.3, 133.0, 132.4, 128.5, 127.7, 127.6, 127.5, 127.4, 127.0, 118.2, 117.9, 114.4, 104.9, 38.5, 32.0, 29.2, 24.7, 24.5, 23.6, 22.6, 20.6, 14.4, 13.9; HRMS (FAB-Magnetic Sector): calcd for C14H19N2 [M + H]+, 215.1548; found, 215.1570. 4-Amino-2-butyl-8-methylquinoline (3e) General procedure was followed with 2-amino-3-methylbenzonitrile (66.1 mg, 0.500 mmol) and 1-hexyne (45.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 3e as a white solid (Method A: 51.4 mg, 48%; Method B: 88.3 mg, 83% (3e + 3e′)): 1H NMR (500 MHz, CDCl3): δ 7.57 (d, J = 8.2 Hz, 1H), 7.47 (d, J = 6.9 Hz, 1H), 7.27 (dd, J = 8.2, 7.3 Hz, 1H), 6.51 (s, 1H), 4.58 (br s, 2H), 2.84 (t, J = 7.8 Hz, 2H), 2.77 (s, 3H), 1.82–1.74 (m, 2H), 1.43 (sext, J = 7.5 Hz, 2H), 0.96 (t, J = 7.3 Hz, 3H); 13C­{1H} NMR (125 MHz, CDCl3): δ 162.2, 149.6, 147.7, 137.2, 129.5, 123.6, 117.8, 117.5, 103.6, 39.1, 31.9, 22.7, 18.7, 14.2; HRMS (FAB-Magnetic Sector): calcd for C14H19N2 [M + H]+, 215.1548; found, 215.1544. 4-Amino-2-butyl-6,7-dimethoxyquinoline (3f) and 4-Amino-2-methyl-3-propyl-6,7-dimethoxyquinoline (3f′) General procedure was followed with 2-amino-4,5-dimethoxybenzonitrile (98 mg, 0.50 mmol) and 1-hexyne (45.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 3f + 3f′ as a white solid (Method B: 38.6 mg, 30%, 3f/3f′ = 55/45): For 3f; 1H NMR (400 MHz, CDCl3): δ 7.36 (s, 1H), 7.16 (s, 1H), 6.43 (s, 1H), 5.56 (br s, 2H), 3.95 (s, 3H), 3.94 (s, 3H), 2.74 (t, J = 8 Hz, 2H), 1.73–1.65 (m, 2H), 1.36 (sext, 2H, J = 7.2 Hz), 0.89 (t, 3H, J = 7.2 Hz); For 3f′; 1H NMR (400 MHz, CDCl3): δ 7.32 (s, 1H), 7.16 (s, 1H), 5.45 (br s, 2H), 3.98 (s, 3H x 2, overlap), 2.60 (s, 3H), 2.58–2.54 (m, 2H), 1.61–1.51 (m, 2H), 1.05 (s, 3H, J = 7.2 Hz); 13C NMR (100 MHz, CDCl3): δ 159.5, 153.4, 152.5, 152.0, 150.5, 148.2, 148.0, 147.6, 143.0, 140.0, 112.8, 111.4, 111.2, 106.0, 105.3, 102.2, 99.9, 99.8, 56.22 (x2), 56.16, 56.0, 37.4, 32.0, 28.8, 22.5, 21.8, 21.1, 14.3, 13.8; HRMS (FAB-Magnetic Sector): calcd for C15H21N2O2 [M + H]+, 261.1603; found, 261.1603. 4-Amino-2-butyl-5-chloroquinoline (3g) General procedure was followed with 2-amino-6-chlorobenzonitrile (76.3 mg, 0.500 mmol) and 1-hexyne (45.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 3g as a white solid (Method A: 7 mg, 6%; Method B: 28.1 mg, 24%): 1H NMR (500 MHz, CDCl3): δ 7.81 (d, J = 8.8 Hz, 1H), 7.39 (t, J = 8.8 Hz, 1H), 7.26 (d, J = 8.8 Hz, 1H), 6.41 (s, 1H), 5.78 (br s, 2H), 2.73 (t, J = 7.6 Hz, 2H), 1.74–1.66 (m, 2H), 1.38 (sext, J = 7.6 Hz, 2H), 0.94 (t, J = 7.6 Hz, 3H); 13C­{1H} NMR (125 MHz, CDCl3): δ 163.3, 151.2, 151.1, 128.9, 128.7, 128.5, 126.4, 115.1, 105.2, 38.4, 31.9, 22.6, 14.0; HRMS (FAB-Magnetic Sector): calcd for C13H16ClN2 [M + H]+, 235.1002; found, 235.1026. 4-Amino-2-butyl-7-chloroquinoline (3h) General procedure was followed with 2-amino-4-chlorobenzonitrile (76.3 mg, 0.500 mmol) and 1-hexyne (45.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 3h as a white solid (Method A: 78.4 mg, 67%; Method B: 64.2 mg, 55%); 1H NMR (500 MHz, DMSO-d 6): δ 8.14 (d, J = 8.6 Hz, 1H), 7.70 (d, J = 2.3 Hz, 1H), 7.34 (dd, J = 8.6, 2.3 Hz, 1H), 6.85 (br s, 2H), 6.47 (s, 1H), 2.66 (t, J = 7.7 Hz, 2H), 1.66 (quint, J = 7.6 Hz, 2H), 1.34 (sext, J = 7.3 Hz, 2H), 0.91 (t, J = 7.2 Hz, 3H); 13C­{1H} NMR (125 MHz, DMSO-d 6): δ 163.5, 151.9, 149.0, 133.5, 126.6, 124.4, 123.1, 115.9, 101.9, 37.9, 31.3, 22.0, 13.9; HRMS (FAB-Magnetic Sector): calcd for C13H16ClN2 [M + H]+, 235.1002; found, 235.0998. 4-Amino-2-butyl-6-nitroquinoline (3i) General procedure for method B was followed with 2-amino-5-nitrobenzonitrile (81.6 mg, 0.500 mmol) and 1-hexyne (45.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 5:5:0.2) afforded 3i as an orange oil (66.8 mg, 55%); 1H NMR (400 MHz, CDCl3): δ 8.85 (d, J = 2.7 Hz, 1H), 8.33 (dd, J = 9.1, 2.3 Hz, 1H), 7.98 (d, J = 9.6 Hz, 1H), 6.62 (s, 1H), 5.37 (br s, 2H), 2.83 (t, J = 7.8 Hz, 2H), 1.75 (quint, J = 7.7 Hz, 2H), 1.41 (sext, J = 7.4 Hz, 2H), 0.94 (t, J = 7.3 Hz, 3H); 13C­{1H} NMR (100 MHz, CDCl3): δ 167.5, 151.6, 151.2, 143.1, 130.2, 122.8, 118.4, 116.2, 104.3, 39.0, 31.8, 22.6, 13.9; HRMS (FAB-Magnetic Sector): calcd for C13H16N3O2 [M + H]+, 246.1243; found, 246.1243. 4-Amino-2-butyl-7-trifluoromethylquinoline (3j) General procedure for method B was followed with 2-amino-5-trifluoromethylbenzonitrile (163 mg, 1.00 mmol) and 1-hexyne (90 mg, 1.1 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 5:5:0.2) afforded 3j as a yellow solid (229 mg, 87%); 1H NMR (400 MHz, CDCl3): δ 8.26 (s, 1H), 7.83 (d, J = 8.4 Hz, 1H), 7.50 (d, J = 8.4 Hz, 1H), 6.58 (s, 1H), 5.05 (br s, 2H), 2.81 (t, J = 8.0 Hz, 2H), 1.75–1.71 (m, 2H), 1.42–1.37 (m, 2H), 0.92 (t, J = 7.6 Hz, 3H); 13C­{1H} NMR (100 MHz, CDCl3): δ 165.0, 149.7, 147.7, 130.9 (J C–F = 32.2 Hz), 126.6, 123.9 (J C–F = 271.5 Hz), 121.5, 119.3 (J C–F = 16.3 Hz), 104.5, 38.9, 31.9, 22.5, 13.8; 19F NMR (376 MHz, CDCl3): δ −62.6; HRMS (FAB-Magnetic Sector): calcd for C14H16F3N2 [M + H]+, 269.1266; found, 269.1261. Gram-Scale Synthesis of 6aa To a screw-capped tube (30 mL) with a stir bar in a N2-filled glovebox, toluene (17 mL), ethynylbenzene (0.96 g, 9.3 mmol), InBr3 (3.0 g, 8.5 mmol), and 2-aminobenzonitrile (1.0 g, 8.5 mmol) were successively added. The tube was then sealed and removed from the glovebox, and heated at 120 °C (bath temperature) for 1 h. After this time, the reaction mixture was quenched using a saturated aqueous Na2CO3 solution (30 mL). The aqueous layer was extracted with chloroform (3 × 30 mL), and the combined organic layer was dried over Na2SO4, filtered, evaporated under reduced pressure. The crude material was purified by recrystallization to yield 2-phenyl-4-aminoquinoline (6aa) as a white solid (1.25 g, 67%). 4-Amino-2-phenylquinoline (6aa) General procedure for method A was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and ethynylbenzene (56.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 6aa as a white solid (Method A: 78.1 mg, 71%); 1H NMR (500 MHz, DMSO-d 6): δ 8.16 (d, J = 7.4 Hz, 1H), 8.09 (dd, J = 7.4, 7.4 Hz, 2H), 7.84 (d, J = 7.4 Hz, 1H), 7.61 (t, J = 7.4 Hz, 1H), 7.49 (t, J = 7.4 Hz, 2H), 7.44–7.41 (m, 1H), 7.38 (t, J = 7.4 Hz, 1H), 7.12 (s, 1H), 6.85 (br s, 2H); 13C­{1H} NMR (125 MHz, DMSO-d 6): δ 156.2, 152.4, 148.8, 140.0, 129.3, 129.2, 128.8, 128.5, 126.8, 123.5, 122.2, 117.8, 99.1; HRMS (FAB-Magnetic Sector): calcd for C15H13N2 [M + H]+, 221.1079; found, 221.1073. 4-Amino-2-(4-methylphenyl)­quinoline (6ab) General procedure for method A was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and 1-ethynyl-4-methylbenzene (63.9 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 6ab as a white solid (60.9 mg, 52%): 1H NMR (500 MHz, CDCl3): δ 8.07 (d, J = 8.0 Hz, 1H), 7.97 (d, J = 8.0 Hz, 2H), 7.75 (d, J = 7.6 Hz, 1H), 7.66 (t, J = 6.8 Hz, 1H), 7.43 (t, J = 6.8 Hz, 1H), 7.29 (d, J = 7.6 Hz, 2H), 7.06 (s, 1H), 4.73 (br s, 2H), 2.42 (s, 3H); 13C­{1H} NMR (100 MHz, CDCl3): δ 158.0, 149.9, 149.1, 139.0, 137.4, 130.1, 129.5, 129.3, 127.3, 124.5, 119.9, 117.9, 101.4, 21.3; HRMS (FAB-Magnetic Sector): calcd for C16H15N2 [M + H]+, 235.1235; found, 235.1261. 4-Amino-2-(3-methylphenyl)­quinoline (6ac) General procedure for method A was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and 1-ethynyl-3-methylbenzene (63.9 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 6ac as a white solid (87.8 mg, 75%); 1H NMR (500 MHz, DMSO-d 6): δ 8.20 (d, J = 8.4 Hz, 1H), 7.96 (s, 1H), 7.89 (dd, J = 8.4, 7.6 Hz, 2H), 7.66 (t, J = 7.6 Hz, 1H), 7.45–7.41 (m, 2H), 7.30 (d, J = 7.6 Hz, 1H), 7.16 (s, 1H), 6.84 (br s, 2H), 2.46 (s, 3H); 13C­{1H} NMR (125 MHz, DMSO-d 6): δ 156.3, 152.3, 148.8, 139.9, 137.5, 129.4, 129.2, 129.1, 128.4, 127.4, 123.9, 123.4, 122.2, 117.8, 99.1, 21.2; HRMS (FAB-Magnetic Sector): C16H15N2 [M + H]+, 235.1235; found, 235.1256. 4-Amino-2-(4-trifluoromethylphenyl)­quinoline (6ad) General procedure for method A was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and 1-ethynyl-4-(trifluoromethyl)­benzene (93.6 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 6ad as a white solid (109.5 mg, 76%): 1H NMR (400 MHz, CDCl3): δ 8.18 (d, J = 8.2 Hz, 2H), 8.09 (d, J = 8.2 Hz, 1H), 7.79–7.68 (m, 4H), 7.48 (t, J = 8.9 Hz, 1H), 7.07 (d, J = 7.3 Hz, 1H), 4.82 (br s, 2H); 13C­{1H} NMR (100 MHz, CDCl3): δ 156.4, 150.3, 149.0, 143.6 (q, J C–F = 1.4 Hz), 130.7 (q, J C–F = 32.1 Hz), 130.3, 129.9, 127.7, 125.5 (q, J C–F = 3.8 Hz), 125.1, 124.4 (q, J C–F = 271 Hz), 119.9, 117.9, 101.3; 19F NMR (376 MHz, CDCl3): δ −62.4; HRMS (FAB-Magnetic Sector): calcd for C16H12F3N2 [M + H]+, 289.0953; found, 289.0979. 4-Amino-2-(4-fluorophenyl)­quinoline (6ae) General procedure for method A was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and 1-ethynyl-4-fluorobenzene (66.1 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 6ae as a white solid (83.3 mg, 70%); 1H NMR (400 MHz, DMSO-d 6): δ 8.17–8.11 (m, 3H), 7.83 (d, J = 8 Hz, 1H), 7.61 (t, J = 7.5 Hz, 1H), 7.37 (t, J = 7.5 Hz, 1H), 7.31 (t, J = 8.5 Hz, 2H), 7.09 (s, 1H), 6.89 (br s, 2H); 13C­{1H} NMR (100 MHz, DMSO-d 6): δ 164.0 (d, J C–F = 245.3 Hz), 156.9, 153.8, 148.7, 136.5 (d, J C–F = 2.9 Hz), 131.3, 130.3 (d, J C–F = 8.6 Hz), 128.8, 125.4, 122.8, 118.3, 116.5 (d, J C–F = 21.1 Hz), 100.9; 19F NMR (376 MHz, CDCl3): δ −112.9; HRMS (FAB-Magnetic Sector): calcd for C15H12FN2 [M + H]+, 239.0985; found, 239.0989. 4-Amino-2-(3-fluorophenyl)­quinoline (6af) General procedure for method A was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and 1-ethynyl-3-fluorobenzene (66.1 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 6af as a white solid (89.3 mg, 75%); 1H NMR (500 MHz, DMSO-d 6): δ 8.19 (d, J = 7.4 Hz, 1H), 7.91–7.89 (m, 2H), 7.86 (d, J = 7.4 Hz, 1H), 7.62 (t, J = 7.4 Hz, 1H), 7.52 (q, J = 7.4 Hz, 1H), 7.39 (t, J = 8.0 Hz, 1H), 7.27–7.23 (m, 1H), 7.15 (s, 1H), 6.92 (br s, 2H); 13C­{1H} NMR (125 MHz, DMSO-d 6): δ 162.6 (d, J C–F = 242.6 Hz), 154.7, 152.6, 148.7, 142.6 (d, J C–F = 7.2 Hz), 130.5 (d, J C–F = 8.4 Hz), 129.5, 129.2, 123.8, 122.7, 122.2, 117.9, 115.5 (d, J C–F = 21.7 Hz), 113.3 (d, J C–F = 22.9 Hz), 99.1; 19F NMR (470 MHz, CDCl3): δ −112.9; HRMS (FAB-Magnetic Sector): calcd for C15H12FN2 [M + H]+, 239.0985; found, 239.1008. 4-Amino-2-(3-thienyl)­quinoline (6ag) General procedure was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and 3-ethynylthiophene (59.5 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 5:5:0.2) afforded 6ag as a white solid (Method A: 50.9 mg, 45%; Method B: 37.3 mg, 33%): 1H NMR (400 MHz, CDCl3): δ 8.03 (d, J = 8.2 Hz, 1H), 7.92 (d, J = 1.8 Hz, 2H), 7.75 (d, J = 4.6 Hz, 1H), 7.70 (d, J = 8.2 Hz, 1H), 7.63 (t, J = 7.8 Hz, 1H), 7.40–7.37 (m, 2H), 6.93 (s, 1H), 4.78 (br s, 2H); 13C­{1H} NMR (100 MHz, CDCl3): δ 153.8, 149.9, 148.9, 143.0, 129.8, 129.5, 126.7, 125.9, 124.4, 119.9, 117.9, 101.3; HRMS (FAB-Magnetic Sector): calcd for C13H11N2S [M + H]+, 227.0643; found, 227.0643. 4-Amino-5-fluoro-2-phenylquinoline (6ka) General procedure for method A was followed with 2-amino-6-fluorobenzonitrile (74.9 mg, 0.500 mmol)­and ethynylbenzene (56.2 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 6ka as a white solid (Method A: 54.5 mg, 46% Method B 102.9 mg, 86%); 1H NMR (500 MHz, CDCl3): δ 8.03 (d, J = 7.6 Hz, 2H), 8.09 (d, J = 8.8 Hz, 1H), 7.51–7.42 (m, 4H), 7.00 (d, J = 7.6 Hz, 1H), 6.92 (s, 1H, ArH), 5.39 (br s, 2H); 13C NMR­(125 MHz, CDCl3): δ 160.9, 158.6 (d, J C–F = 288.0 Hz), 150.8 (d, J C–F = 105.4 Hz), 139.7, 129.2, 128.9, 128.7, 128.6, 127.4, 125.9 (d, J C–F = 3.9 Hz), 109.0, 108.9, 108.5, 108.5, 101.8; 19F NMR (470 MHz, CDCl3): δ −115.3, HRMS (FAB-Magnetic Sector): calcd for C15H12FN2 [M + H]+, 239.0885; found, 239.0989. 4-Amino-3-(1-chloropropyl)-2-methylquinoline (8) General procedure was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and 6-chloro-1-hexyne (64.1 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 8 as a white solid (Method A: 27 mg, 23%); 1H NMR (500 MHz, CDCl3): δ 7.90 (d, J = 8.5 Hz, 1H), 7.70 (d, J = 8.5 Hz, 1H), 7.57 (dd, J = 8.5, 8.5 Hz, 1H), 7.40 (dd, J = 8.5, 8.5 Hz, 1H), 4.89 (br s, 2H), 3.67 (t, J = 6.0 Hz, 2H), 2.86 (t, J = 7.7 Hz, 2H), 2.66 (s, 3H), 2.08–2.02 (m, 2H); 13C­{1H}­NMR (125 MHz, CDCl3): δ 157.9, 146.6, 146.5, 128.7 (overlap), 124.3, 119.9, 117.6, 112.1, 45.2, 30.7, 24.0, 23.6; HRMS (FAB-Magnetic Sector): calcd for C13H16ClN2 [M + H]+, 235.1002; found, 235.1026. Ethyl 4-Aminoquinoline-3-carboxylate (9) General procedure was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and ethyl propiolate (54 mg, 0.55 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 9 as a white solid (Method A: 98.3 mg, 91%); 1H NMR (500 MHz, DMSO-d 6): δ 8.89 (s, 1H), 8.37 (d, J = 7.5 Hz, 1H), 8.35 (br s, 2H), 7.80 (d, J = 7.5 Hz, 1H), 7.73 (dd, J = 7.5, 7.5 Hz, 1H), 7.50 (dd, J = 7.5, 7.5 Hz, 1H), 4.32 (q, J = 7 Hz, 2H), 1.33 (t, J = 7 Hz, 3H); 13C­{1H} NMR (125 MHz, DMSO-d 6): δ 167.5, 154.2, 151.2, 148.8, 131.5, 129.1, 125.2, 123.2, 118.1, 99.5, 60.2, 14.2; HRMS (FAB-Magnetic Sector): calcd for C12H13N2O2 [M + H]+, 217.0977; found, 217.0978. 4-Aminoquinoline (10) General procedure was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and trimethylsilylacetylene (54 mg, 0.55 mmol) for 1 h. Silica gel column chromatography (eluent: CHCl3/MeOH/NEt3 = 5:1:0.12) afforded 10 as a white solid (Method A: 44.3 mg, 62%; Method B: complex mixture); 1H NMR (400 MHz, CDCl3): δ 8.52 (d, J = 5.2 Hz, 1H), 8.00 (d, J = 8 Hz, 1H), 7.78 (d, J = 8 Hz, 1H), 7.65 (dd, J = 8, 8 Hz, 1H), 7.45 (dd, J = 8, 8 Hz, 1H), 6.59 (d, J = 5.2 Hz, 1H), 4.95 (br s, 2H); 13C­{1H} NMR (100 MHz, CDCl3): δ 150.6, 149.6, 148.7, 129.8, 129.4, 124.8, 120.2, 118.7, 103.7; HRMS (FAB-Magnetic Sector): calcd for C9H9N2 [M + H]+, 145.0766; found, 145.0768. 4-Amino-2,3-dipentylquinoline (11) General procedure was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and 6-dodecyne (91.5 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 11 as a colorless oil (Method A: 65.3 mg, 46%; Method B: 84.6 mg, 60%); 1H NMR (400 MHz, CDCl3): δ 7.93 (d, J = 8 Hz, 1H), 7.68 (d, J = 8 Hz, 1H), 7.55 (dd, J = 8, 8 Hz, 1H), 7.35 (dd, J = 8, 8 Hz, 1H), 4.68 (br s, 2H), 2.91–2.87 (m, 2H), 2.68–2.63 (m, 2H), 1.76–1.71 (m, 2H), 1.62–1.55 (m, 2H), 1.48–1.33 (m, 8H), 1.01–0.89 (m, 6H); 13C­{1H} NMR (100 MHz, CDCl3): δ 161.9, 146.5, 146.2, 129.0, 128.2, 124.0, 119.8, 117.6, 113.8, 36.7, 32.2, 29.9, 28.2, 27.0, 22.6, 22.5, 14.0, 13.9 (overlap); HRMS (FAB-Magnetic Sector): calcd for C19H29N2 [M + H]+, 285.2331; found, 285.2336. 4-Amino-2,3-diphenylquinoline (12) General procedure was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) and diphenylacetylene (98 mg, 0.55 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 5:5:0.2) afforded 12 as a colorless solid (Method B: 73.1 mg, 49%); 1H NMR (400 MHz, CDCl3): δ 8.11 (d, J = 9.2 Hz, 1H), 7.79 (d, J = 8.0 Hz, 1H), 7.69 (dd, J = 15.2, 1.2 Hz, 1H), 7.50 (dd, J = 15.2, 1.2 Hz, 1H), 7.36–7.25 (m, 5H), 7.21–7.15 (m, 5H), 4.75 (br s, 2H); 13C­{1H} NMR (100 MHz, CDCl3): δ 158.8, 147.5, 147.2, 141.2, 136.5, 131.1, 130.1, 129.7, 129.4, 129.0, 127.5, 127.4, 127.3, 125.0, 120.4, 117.4, 116.0; HRMS (FAB-Magnetic Sector): calcd for C21H17N2 [M + H]+, 297.1392; found, 297.1390. 4-Amino-2-hexylquinoline (13) General procedure was followed with 2-aminobenzonitrile (118 mg, 1.00 mmol) and 1-octyne (121 mg, 0.550 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 13 as a brown oil (Method B: 176 mg, 78%); 1H NMR (400 MHz, CDCl3): δ 7.96 (d, J = 7.8 Hz, 1H), 7.75 (d, J = 7.8 Hz, 1H), 7.59 (t, J = 6.8 Hz, 1H), 7.39 (t, J = 6.8 Hz, 1H), 6.52 (s, 1H), 4.89 (br s, 2H), 2.80 (t, J = 8 Hz, 2H), 1.76–1.72 (m, 2H), 1.45–1.39 (m, 2H), 1.35–1.30 (m, 4H), 0.86 (t, J = 7.4 Hz, 3H); 13C­{1H} NMR (100 MHz, CDCl3): δ 163.2, 149.9, 148.2, 129.4, 128.7, 124.1, 120.1, 117.5, 103.2, 39.1, 31.7, 30.0, 29.3, 22.5, 14.0; HRMS (FAB-Magnetic Sector): calcd for C15H21N2 [M + H]+, 229.1699; found, 229.1704. 2-Methyl-3-propyl-4-aminoquinoline (14) General procedure was followed with 2-aminobenzonitrile (118 mg, 1.00 mmol) and 2-hexyne (90 mg, 1.1 mmol) for 1 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 14 as a pale yellow solid (Method B: 15 mg, 8%); 1H NMR (400 MHz, CDCl3): δ 7.90 (d, J = 8 Hz, 1H), 7.69 (d, J = 8 Hz, 1H), 7.57 (dd, J = 7.2 Hz, 6 Hz, 1H), 7.38 (dd, J = 7.2 Hz, 6 Hz, 1H), 4.62 (br s, 2H), 2.69–2.65 (m, 2H), 2.67 (s, 3H), 1.63 (sext, J = 7.6 Hz, 2H), 1.09 (t, J = 7.6 Hz, 3H); 13C­{1H} NMR (100 MHz, CDCl3) d 158.3, 146.4, 140.0, 129.0, 128.4, 124.2, 119.7, 117.8, 114.1, 29.5, 23.9, 21.3, 14.5; HRMS (FAB-Magnetic Sector): m/s Calcd for C13H17N2 (M++H): 201.1392; Found: 201.1391. General Procedure for the Synthesis of 4-Aminoquinazoline Derivatives (Method A) To a screw-capped vial with a stir bar in a N2-filled glovebox, a 2-amino-4-methylbenzonitrile derivative (0.5 mmol), GaCl3 (88.4 mg, 0.500 mmol), and toluene (0.8 mL) were successively added. The vial was then sealed and removed from the glovebox, and the mixture was heated at 120 °C (bath temperature) for 20 h. After this time, the resulting mixture was quenched using a saturated aqueous Na2CO3 solution (5 mL), and the aqueous layer was extracted with chloroform (10 × 2 mL). The combined organic layer was dried over Na2SO4, filtered, and evaporated. The crude material was purified by silica gel column chromatography (eluent: hexane/ethyl acetate = 4:1) to yield the corresponding 4-aminoquinazoline derivative. General Procedure for the Synthesis of 4-Aminoquinazoline Derivatives (Method B) To a screw-capped vial with a stir bar in a N2-filled glovebox, a 2-amino-4-methylbenzonitrile derivative (0.5 mmol), InBr3 (177 mg, 0.500 mmol), and toluene (0.8 mL) were successively added. The vial was then sealed and removed from the glovebox, and the mixture was then heated at 120 °C (bath temperature) for 20 h. After this time, the resulting mixture was quenched using a saturated aqueous Na2CO3 solution (5 mL), and the aqueous layer was extracted with chloroform (10 × 2 mL). The combined organic layer was dried over Na2SO4, filtered, and evaporated. The crude material was purified by silica gel column chromatography (eluent: hexane/ethyl acetate = 4:1) to yield the corresponding 4-aminoquinazoline derivative. 4-Amino-2-(2-aminophenyl)­quinazoline (16) General procedure was followed with 2-aminobenzonitrile (59.1 mg, 0.500 mmol) for 20 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 16 as a colorless solid (Method A: 37.6 mg, 64%; Method B: 5.0 mg, 8%); 1H NMR (400 MHz, CDCl3): δ 8.44 (dd, J = 7.8, 1.6 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.70 (ddd, J = 8.2, 6.8, 1.2 Hz, 2H) 7.65 (d, J = 8.4 Hz, 1H), 7.37­(ddd, J = 8.2, 6.8, 1.2 Hz, 1H) 7.21 (ddd, J = 8.2, 6.8, 1.2 Hz, 1H) 6.77 (m, 2H), 6.49 (s, 2H), 5.74 (s, 2H); 13C­{1H} NMR (100 MHz, CDCl3): δ 162.1, 160.6, 149.9, 148.7, 133.1, 131.1, 130.9, 128.1, 125.4, 121.6, 119.7, 116.9, 116.7, 112.4; MS­(EI) m/z 236; HRMS (FAB-Magnetic Sector): calcd for C14H13N4 [M + H]+, 237.1140; found, 237.1141. 4-Amino-2-(2-amino-4-methylphenyl)-7-methylquinazoline (4) General procedure was followed with 2-amino-4-methylbenzonitrile (66.1 mg, 0.500 mmol) for 20 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 4 as a colorless solid (Method A: 35 mg, 53%; Method B: 36 mg, 53%); 1H NMR (400 MHz, CDCl3): δ 8.34 (d, J = 8 Hz, 1H), 7.62 (s, 1H), 7.59 (d, J = 8 Hz, 1H), 7.22 (d, J = 8 Hz, 1H), 6.58 (d, J = 8 Hz, 1H), 6.55 (s, 1H), 5.55 (br s, 2H), 2.51 (s, 3H), 2.29 (s, 3H); 13C­{1H} NMR (100 MHz, CDCl3): δ 162.3, 160.4, 150.2, 148.9, 143.9, 141.5, 131.0, 127.34, 127.26, 121.5, 118.1, 117.4, 117.2, 110.3, 22.0, 21.5; HRMS (FAB-Magnetic Sector): calcd for C16H17N4 [M + H]+, 265.1453; found, 265.1447. 4-Amino-2-(2-amino-4-chlorophenyl)-7-chloroquinazoline (17) General procedure was followed with 2-amino-4-chlorobenzonitrile (76.3 mg, 0.500 mmol) for 20 h. Silica gel column chromatography (eluent: hexane/EtOAc/NEt3 = 4:1:0.1) afforded 17 as a colorless solid (Method A: 52.9 mg, 69%; Method B: 8.3 mg, 11%); 1H NMR (400 MHz, DMSO-d 6): δ 8.34 (d, J = 8 Hz, 1H), 8.18 (d, J = 8 Hz, 1H), 7.94 (s, 2H), 7.79 (s, 1H), 7.58 (s, 2H), 7.43 (d, J = 8.8 Hz, 1H), 6.78 (s, 1H), 6.52 (d, J = 8.8 Hz, 1H); 13C­{1H} NMR (100 MHz, DMSO-d 6): δ 162.3, 160.8, 151.1, 150.4, 137.5, 135.2, 132.2, 125.8, 125.5, 125.0, 116.0, 114.9, 113.9, 110.9; HRMS (FAB-Magnetic Sector): calcd for C14H11Cl2N4 [M + H]+, 305.0361; found, 306.0355. Supplementary Material